CHICAGO — At the Ophthalmology Innovation Summit here, Barry J. Linder, MD, MS, chief medical officer for Clarity Medical Systems, discusses the launch of the Holos-Barrett IOL algorithm.
Uncategorized
Uncategorized
VIDEO: Ocular Therapeutix announces collaboration with Regeneron
CHICAGO — At the Ophthalmology Innovation Summit here, Amar Sawhney, PhD, president and CEO of Ocular Therapeutix, discusses the collaboration announced today between Ocular Therapeutix and Regeneron to develop an extended release formulation of Eylea (aflibercept).
Uncategorized
VIDEO: Luminate meets primary, secondary endpoints in phase 2b trial
CHICAGO — At the Ophthalmology Innovation Summit here, Vicken Karageozian, MD, president and chief medical officer of Allegro Ophthalmics, discusses the results of the phase 2b DEL MAR clinical trial of Luminate for treating diabetic macular edema. In the controlled, double-masked, multicenter, dose-ranging study, Luminate (ALG-1001) met both its primary endpoint for visual acuity and secondary endpoint for reduction in central macular thickness as measured by OCT.
A First Glimpse into Disc Shedding in the Human Eye
WASHINGTON–(BUSINESS WIRE)–#OSA_BoEx–This glimpse into the eye will help scientists better understand, prevent and manage major eye diseases that affect photoreceptors like age-related macular degeneration and retinitis pigmentosa.
FGX International Introduces Item 8
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, announces the launch of Item 8™, a new line of designer sunglasses from the globally recognized eyewear brand, Foster Grant. The Item 8 launch collection features chic, modern designs drawn from worldwide trends and curated by Foster Grants’ design team. Item 8 sunglasses are available online at item8eyewear.com, with retail distribution in department and specialty stores in the U.S starting in 2017.
Alpine Capital, LLC Announces Senior Secured Financing to Claris Vision Holdings
CHARLOTTE, N.C.–(BUSINESS WIRE)–Alpine Capital, LLC announced today that it has provided $7.5 million in financing, which consisted of a $3 million senior secured revolving line of credit, a $2.5 million senior secured term loan, and a $2 million equ…